September 29, 2026 at 12:47 PM UTC
Moleculin Biotech, Inc. issues Regulation FD disclosure
Moleculin Biotech, Inc. filed an 8-K covering a Regulation FD disclosure. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.
Official source: U.S. Securities and Exchange Commission
Official source published: September 29, 2026 at 12:45 PM UTC
Open official source